document

1
Nature © Macmillan Publishers Ltd 1998 8 [JERUSALEM] Despite objections from some industrialists and government officials, Israeli Prime Minister Binyamin Netanyahu decided this week that Israel should partici- pate in the European Union’s fifth four-year Framework programme of research (FP5), which begins next year. Netanyahu authorized the Israeli negoti- ating team to initial the agreement it had reached with the EU. But the agreement still requires the approval of the cabinet and of the finance committee of the Knesset, Israel’s parliament. The negotiating team, led by Orna Berry, chief scientist at the Ministry of Commerce and Industry, achieved what Berry said were significant improvements over the rules Israel worked under in the fourth Frame- work programme (FP4). This would put Israel on a par with the non-EU European states that participate, such as Norway. Berry has been a strong supporter of Israel’s continued participation, as a way of strengthening the country’s presence in the European market for high-technology goods. But she does not dispute the claim levelled by the programme’s opponents — that Israel is getting terms that are less good than those enjoyed by EU member states. The FP5 rules require, for example, that Israel can only participate in projects involv- ing at least two EU countries, while EU mem- bers need only find one other member state as a partner. But she argues that Israel cannot afford to remain outside the programme. Israel’s high-tech industries must under- stand, says Berry, that Framework is a Euro- pean programme not designed with the interests of non-EU countries in mind. “We pay in advance, and we have to adjust our- selves to the EU’s requirements,” she says. Berry points out that Israel has a trade deficit of US$10 billion with Europe, half of the total value of the country’s exports to the EU. She says Israel has already, through its membership of FP4, invested money and effort in becoming familiar with the pro- gramme and the Brussels bureaucracy. Not joining FP5 would mean writing off that investment, she says. Berry’s arguments are supported by many in universities. “Israel must join [FP5],” says Zehev Tadmor, president of the Technion — Israel Institute of Technology. “Europe is our natural partner and it would be absurd if we were not in the programme.” Technion researchers are involved in 17 research projects funded under FP4, in fields as diverse as aeronautics, medical technol- ogy and water desalination. “True, it’s a big bureaucracy, but we’ve got to overcome that,” says Tadmor. news NATURE | VOL 393 | 18 JUNE 1998 611 But the programme’s critics in industry and government disagree. Officials at the sci- ence and finance ministries have been argu- ing that the money Israel will have to invest in the programme — about $45 million annu- ally over four years — could be better spent in direct grants to local research projects. Some leading figures in the country’s high- tech industries have been overtly hostile. Zohar Zisapel, chairman of Rad Data Communications and of the Electronic Industries Association, argues that “Israel has been accepted into the programme under discriminatory conditions, and as a result has not been able fully to realize the opportunities it presented”. Zisapel points out that, under the rules covering the participation of non-EU states in FP4, Israeli companies have not been able to act as the coordinators of research pro- grammes. Such restrictions come on top of the inherent disadvantages Israel faces as a non-EU member of the programme. He suggests that Israel should be given not just a level playing field, but one tilted in its favour, arguing that European high-tech companies “have a lot more good reasons to want to cooperate with Israeli companies” than Israeli companies have to want to co- operate with European ones. Uri Shor, spokesman of the Ministry of Science, says Israel should participate in the programme, but only on the same condi- tions enjoyed by member states. “We won’t invest the money of Israeli taxpayers for other people’s research programmes.” The prime minister’s science adviser, Israel Hanukoglu, says: “We pay the full assessment but we don’t get the whole pro- gramme. We’re very interested in participat- ing, but we want equal conditions.” However, the programme’s opponents are unlikely to campaign against the agree- ment’s ratification by the cabinet and Knesset. Haim Watzman Israel reaches deal to join EU Framework programme Job discrimination based on genetics set for California ban [SAN FRANCISCO] The California senate is expected to finalize legislation this week to prohibit employers from discriminating on the basis of genetic characteristics. The bill, which the State Assembly approved last week, was expected to go to the governor Pete Wilson before Friday for a final signature. The law would prevent employers from using any genetic information — including tests, family histories or conjectures from someone’s appearance or ethnicity — in making hiring, promotion or other job- related decisions. California already has one of the coun- try’s strongest laws prohibiting insurance- related genetic discrimination. State senator Patrick Johnston (Democrat, Sacramento/ San Joaquin), who shepherded that legisla- tion four years ago, has been pursuing restrictions on gene-related employment dis- crimination ever since. “Job applicants should not be evaluated based on their genes,” Johnston told the Assembly Appropriations Committee. “They should be evaluated based on their perfor- mance, their current health status, and their actual capacity to function in a job.” Johnston said several studies suggest that employers are using genetic information to deny employment to individuals. Companies may be attempting to avoid high health- insurance rates or a loss of productivity once a genetic disease strikes. The Chamber of Commerce and the Cali- fornia Manufacturers Association opposed the legislation, but the pharmaceutical com- pany SmithKline Beecham supported it. The Biotechnology Industry Organization has argued against a patchwork of non-discrimi- nation laws at the state level, pointing out that there is already some federal protection, such as the Americans with Disabilities Act. Johnston said that state laws on genetic discrimination are necessary because the existing act may not fully protect workers. In addition, the federal Disabilities Act covers only companies with at least 15 employees; the new law would apply to any employer of more than five people. The California legisla- tion could lead the way for other states to enact strict laws against genetic discrimina- tion in employment. At the national level, a bill sponsored by Representative Louise Slaughter (Democrat, New York) and Senator Olympia Snowe (Republican, Maine) is scheduled for mark- up in the US Senate Labor and Human Resources Committee this week. Legislators are expected to vote on the bill, which is intended to prevent discrimination by health insurers on the basis of genetic information, within a month. Sally Lehrman Netanyahu: backs Framework deal despite claims that the rules discriminate against Israel. AP/MATI STEIN

Upload: haim

Post on 21-Jul-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: document

Nature © Macmillan Publishers Ltd 1998

8[JERUSALEM] Despite objections from someindustrialists and government officials,Israeli Prime Minister Binyamin Netanyahudecided this week that Israel should partici-pate in the European Union’s fifth four-yearFramework programme of research (FP5),which begins next year.

Netanyahu authorized the Israeli negoti-ating team to initial the agreement it hadreached with the EU. But the agreement stillrequires the approval of the cabinet and ofthe finance committee of the Knesset, Israel’sparliament.

The negotiating team, led by Orna Berry,chief scientist at the Ministry of Commerceand Industry, achieved what Berry said weresignificant improvements over the rulesIsrael worked under in the fourth Frame-work programme (FP4). This would putIsrael on a par with the non-EU Europeanstates that participate, such as Norway.

Berry has been a strong supporter ofIsrael’s continued participation, as a way ofstrengthening the country’s presence in theEuropean market for high-technologygoods. But she does not dispute the claimlevelled by the programme’s opponents —that Israel is getting terms that are less goodthan those enjoyed by EU member states.

The FP5 rules require, for example, thatIsrael can only participate in projects involv-ing at least two EU countries, while EU mem-bers need only find one other member stateas a partner. But she argues that Israel cannotafford to remain outside the programme.

Israel’s high-tech industries must under-stand, says Berry, that Framework is a Euro-pean programme not designed with theinterests of non-EU countries in mind. “Wepay in advance, and we have to adjust our-selves to the EU’s requirements,” she says.

Berry points out that Israel has a tradedeficit of US$10 billion with Europe, half ofthe total value of the country’s exports to theEU. She says Israel has already, through itsmembership of FP4, invested money andeffort in becoming familiar with the pro-gramme and the Brussels bureaucracy. Notjoining FP5 would mean writing off thatinvestment, she says.

Berry’s arguments are supported bymany in universities. “Israel must join[FP5],” says Zehev Tadmor, president of theTechnion — Israel Institute of Technology.“Europe is our natural partner and it wouldbe absurd if we were not in the programme.”

Technion researchers are involved in 17research projects funded under FP4, in fieldsas diverse as aeronautics, medical technol-ogy and water desalination. “True, it’s a bigbureaucracy, but we’ve got to overcomethat,” says Tadmor.

news

NATURE | VOL 393 | 18 JUNE 1998 611

But the programme’s critics in industryand government disagree. Officials at the sci-ence and finance ministries have been argu-ing that the money Israel will have to invest inthe programme — about $45 million annu-ally over four years — could be better spentin direct grants to local research projects.Some leading figures in the country’s high-tech industries have been overtly hostile.

Zohar Zisapel, chairman of Rad DataCommunications and of the ElectronicIndustries Association, argues that “Israelhas been accepted into the programmeunder discriminatory conditions, and as aresult has not been able fully to realize theopportunities it presented”.

Zisapel points out that, under the rulescovering the participation of non-EU statesin FP4, Israeli companies have not been ableto act as the coordinators of research pro-grammes. Such restrictions come on top ofthe inherent disadvantages Israel faces as anon-EU member of the programme.

He suggests that Israel should be givennot just a level playing field, but one tilted inits favour, arguing that European high-techcompanies “have a lot more good reasons towant to cooperate with Israeli companies”than Israeli companies have to want to co-operate with European ones.

Uri Shor, spokesman of the Ministry ofScience, says Israel should participate in theprogramme, but only on the same condi-tions enjoyed by member states. “We won’tinvest the money of Israeli taxpayers forother people’s research programmes.”

The prime minister’s science adviser,Israel Hanukoglu, says: “We pay the fullassessment but we don’t get the whole pro-gramme. We’re very interested in participat-ing, but we want equal conditions.”

However, the programme’s opponentsare unlikely to campaign against the agree-ment’s ratification by the cabinet and Knesset. Haim Watzman

Israel reaches deal to joinEU Framework programme

Job discriminationbased on geneticsset for California ban[SAN FRANCISCO] The California senate isexpected to finalize legislation this week toprohibit employers from discriminating onthe basis of genetic characteristics. The bill,which the State Assembly approved lastweek, was expected to go to the governor PeteWilson before Friday for a final signature.

The law would prevent employers fromusing any genetic information — includingtests, family histories or conjectures fromsomeone’s appearance or ethnicity — inmaking hiring, promotion or other job-related decisions.

California already has one of the coun-try’s strongest laws prohibiting insurance-related genetic discrimination. State senatorPatrick Johnston (Democrat, Sacramento/San Joaquin), who shepherded that legisla-tion four years ago, has been pursuingrestrictions on gene-related employment dis-crimination ever since.

“Job applicants should not be evaluatedbased on their genes,” Johnston told theAssembly Appropriations Committee. “Theyshould be evaluated based on their perfor-mance, their current health status, and theiractual capacity to function in a job.”

Johnston said several studies suggest thatemployers are using genetic information todeny employment to individuals. Companiesmay be attempting to avoid high health-insurance rates or a loss of productivity oncea genetic disease strikes.

The Chamber of Commerce and the Cali-fornia Manufacturers Association opposedthe legislation, but the pharmaceutical com-pany SmithKline Beecham supported it. TheBiotechnology Industry Organization hasargued against a patchwork of non-discrimi-nation laws at the state level, pointing outthat there is already some federal protection,such as the Americans with Disabilities Act.

Johnston said that state laws on geneticdiscrimination are necessary because theexisting act may not fully protect workers. Inaddition, the federal Disabilities Act coversonly companies with at least 15 employees;the new law would apply to any employer ofmore than five people. The California legisla-tion could lead the way for other states toenact strict laws against genetic discrimina-tion in employment.

At the national level, a bill sponsored byRepresentative Louise Slaughter (Democrat,New York) and Senator Olympia Snowe(Republican, Maine) is scheduled for mark-up in the US Senate Labor and HumanResources Committee this week. Legislatorsare expected to vote on the bill, which isintended to prevent discrimination by healthinsurers on the basis of genetic information,within a month. Sally Lehrman

Netanyahu: backs Framework deal despite claimsthat the rules discriminate against Israel.

AP

/MA

TI

STE

IN